S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Home
Investing
Bonds
Europe
EU
Babcock & Wilcox Enterprises Inc 8.125% until 28feb2026 (CADEZ)
Babcock & Wilcox Enterprises Inc 8.125% until 28feb2026 (CADEZ) News

Babcock & Wilcox Enterprises Inc 8.125% until 28feb2026 (CADEZ)

99.80

0.00

( 0.00% )

Updated: 19:00:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

0 articles were found

sam1933

sam1933 6 minutes ago

🚀 Mission Accomplished: The Spacedrop Closes as We Prepare for Launch!

https://spacedrop.sealcoin.ai

lakers17

lakers17 7 minutes ago

Dodgers actually have had the most people on the injury lists this year. Dodgers win again as their bats are on fire with Betts now up to .244 and Edman is back after missing 73 games and is hitting .395. Wrobleski an unknown goes to 10-2 with a 2.80 ERA. Dodgers have a ridiculous 12 game lead o

sam1933

sam1933 24 minutes ago

Q4 2026 (Strategic Launch Anchor): Separate from the financial paperwork but critical to its technical valuation, SEALSQ will launch its QSAT payload via a SpaceX Falcon 9 rocket, establishing its Quantum Spatial Orbital Cloud (QSOC) to anchor the entity’s physical assets.

QS7001: The

tkg

tkg 26 minutes ago

Posted by:

Rodolfo Taylor
Automotive Professional Consultant
14h •

The open PDK manufacturing roadmap is officially breaking out into the wild.

Luceda Photonics has just announced a global webinar series spotlighting the next generation of

1Bigmac

1Bigmac 29 minutes ago

https://www.youtube.com/watch?v=rzefyf-Fy6w

eagle8

eagle8 29 minutes ago

d_stock
@d_stock07734
$NWBO
Eikon Therapeutics, the so-called 'Merck 2.0' cannot fly high without DCVax. TLR 7/8 agonist as its name implies is just an agonist.

In all the trials currently run by Eikon, is there a single one in which DCs have hundreds of tumor-as

Bngo

Bngo 29 minutes ago

What would happen to ELTP share price if next week the large pharmaceutical company visits Elite and makes an offer that is acceptable to Nasrat and a PR is put out for voting of acquisition based on the asking price per share?
And that is why many of us true long ELTP investors will not let

mm41

mm41 30 minutes ago

🚨 Smart money isn’t quitting AI. It’s changing its address 🚨

While retail traders are still chasing parabolic chip charts at 50x sales, a silent, massive migration of institutional capital is happening under the hood.

The market is finally waking up to a

janice shell

janice shell 31 minutes ago

I knew you'd find that... interesting. I see Dan Zinn, general counsel and the guy who seems to deal with a good deal of the day to day management, is still there. He and Paltrowitz used to do presentations and things together, but Zinn was more important. Or thought he was.

This see

eagle8

eagle8 34 minutes ago

d_stock
@d_stock07734
$NWBO

Great find! Thanks
@HenryMuney

UCLA has phase III trial in planning! That's great.

I was confused by the fact that the combo trial stopped enrolling in August 2025 while in the same month Merck p

eagle8

eagle8 39 minutes ago

From 'X'.
We know who.

All Market Makers in the Harrington Spoofing Case Have Settled

The Case: Harrington Global Opportunity Fund, Limited v. BofA Securities, Inc., 1:21-cv-00761, (S.D.N.Y.)

The Docket: https://courtlistener.com/docket/46947528/h

shajandr

shajandr 41 minutes ago

"ADVFN Appoints Jason Paltrowitz as Non-Executive Director"
https://investorshub.advfn.com/uimage/uploads/2023/11/17/vsnrqship_company_meme.jpg
https://investorshub.advfn.com/uimage/uploads/2025/8/22/sgmedwinnie_the_pooh.jpg

https://investorshub.advfn.com/uimage/uploads

Nemesis18

Nemesis18 41 minutes ago

The MHRA & NICE will break their silence shortly, I believe, as the NWBO application has become toxic.

US Market News

US Market News 1 hour ago

NiCE Extends Its AI-Powered Customer Experience Solution to AWS European Sovereign Cloud, Advancing Trusted Agentic AI Across Regulated MarketsJuly 1, 2026 3:05 AM
Business Wire NiCE’s CX AI solution supports digital sovereignty and EU data residency requiremen

Chartallica

Chartallica 1 hour ago

I feel like GRLF can make a strong move above .01 from here.

Chartallica

Chartallica 1 hour ago

I feel like GRLF can make a strong move above .01 from here.

US Market News

US Market News 1 hour ago

NiCE Launches AI Specialization Program, Recognizing Partners Driving Significant AI Outcomes for EnterprisesJuly 1, 2026 3:00 AM
Business Wire Six industry-leading partners — Accenture, Cirrus, Deloitte, Route 101, and TTEC — named as inaugural AI Specializati

US Market News

US Market News 1 hour ago

Teledyne e2v Strengthens Space-Grade ADC Offering with Radiation Robustness ResultsJuly 1, 2026 3:00 AM
Business Wire Teledyne e2v Semiconductors today announced new radiation test results for its EV10AS940, a 10-bit, 12.8 GSps, Ka-band-capable analog-to-digital converter, or A

sam1933

sam1933 1 hour ago

FOR IMMEDIATE RELEASE
https://investorshub.advfn.com/stock-market/NASDAQ/sealsq-LAES/stock-news/98834920/form-6-k-report-of-foreign-issuer-rules-13a-16 SEALSQ and WISeKey Establish Quantisimo Corp. as a Special Purpose Vehicle, and Execute Letter of Intent with GigCapital8 Corp. Proposed St

Mr79

Mr79 2 hours ago

https://media4.giphy.com/media/v1.Y2lkPTZjMDliOTUyMnlyN3RwMHQ5eTdsanM1dXdhYXRycjc5dDBucXV2ODZzZ210MnEydyZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/kc06qPieCwc4rZQ3Te/giphy.gif

Gladiator 83

Gladiator 83 2 hours ago

How many millions of BCAP shares do you hold?
I hope the OTC markets rally someday like they did in January and February 2021 and we get rich; patience pays off.

Gladiator 83

Gladiator 83 2 hours ago

I hope it goes up soon and this thing goes to the moon.

sentiment_stocks

sentiment_stocks 2 hours ago

It sounds like he’s referencing “any new information” regarding the MAA and not Dr. Bosch’s presentation.

Termite7

Termite7 2 hours ago

How high could this go? Thanks.......!!!

Babcock & Wilcox Enterpr...

Xstate Resources

Russell CP Delaware

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN

Already have an account? Sign in

Don't have an account? Sign up

By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.